Saikaya is expected to be designated as a controlled securities (under review) by the Tokyo Stock Exchange, effective September 1, 2026. Suitability is not met based on the free float market capitalization standard; depending on future review results, there is a possibility of delisting.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2927","jir_company_name":"AFC-HD Amus Life Science Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/2927-20260901-01.pdf","jir_short_summary":"Saikaya is expected to be designated as a controlled securities (under review) by the Tokyo Stock Exchange, effective September 1, 2026. Suitability is not met based on the free float market capitalization standard; depending on future review results, there is a possibility of delisting.","jir_summary":"### Background and reason for designation\nThis matter is based on Saikaya, a consolidated subsidiary, whose compliance with the free float market capitalization standard as the maintenance criterion for the Tokyo Stock Exchange Standard Market could not be confirmed as of the last business day, August 31, 2026. The Tokyo Stock Exchange plans to designate it as a controlled securities (under review) as of September 1. If compliance cannot be confirmed, it may be designated as a reorganized issue and delisted on March 1, 2027.\n\n### Future actions and impact\nTo maintain the Standard Market listing, the company will wait for the results of the examination based on the 'Distribution of Shares' table submitted. Depending on the results, it will be determined whether it meets the free float market capitalization standard, and if not, it may proceed to delisting. The anticipated investor impact includes reduced liquidity and increased price volatility of the shares.","jir_financial_highlights":"Free float market capitalization standard: Unknown (Unknown)\nNumber of shareholders: Unknown (Unknown)","jir_category":"","jir_hashtags":"#AFC-HD, #TreasuryStockSecuritiesControl, #ControlledSecuritiesUnderReview","jir_key_figures":"Controlled securities (under review) designation date: 2026-09-01\nFree float market capitalization standard conformity status: Non-conforming\nShareholders: 3,002 people (reference value)","jir_meta_title":"\u3010AFC-HD\u3011Notice on designation of controlled securities (under review) | September 2026","jir_meta_description":"Notice published regarding the designation of the consolidated subsidiary Saikaya as controlled securities (under review). It discloses that the conformity to the free float market capitalization standard could not be confirmed and delisting may occur depending on future review results.","jir_og_title":"AFC-HD Notice of Controlled Securities (Under Review)","jir_og_description":"Publicizing important information regarding Saikaya's designation as controlled securities (under review). Note that delisting may occur depending on conformity.","jir_og_image_url":"\/assets\/og\/company-disclosure_update.jpg","jir_chart_data_collection":"[]","ir_related_company":58627,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-109004","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n